Q. Zhong

Characteristics and prognosis of distant metastasis after primary treatment for early‐stage extranodal nasal‐type natural killer/T‐cell lymphoma from the China Lymphoma Collaborative Group database

Jun Zhu, Yu-jing Zhang, S. Qi, 2022, EJHaem.

Risk stratification and prognostic value of multi-modal MRI-based radiomics for extranodal nasal-type NK/T-cell lymphoma

J. Dai, Chen Hu, K. Men, 2023, BMC Cancer.

Outcome and risk prediction of early progression in patients with extranodal natural killer/T cell lymphoma from the CLCG study

Jun Zhu, Shulian Wang, Yu-jing Zhang, 2023, Annals of Hematology.

Efficacy and Safety of Anlotinib in Patients with Advanced Non-Small Cell Lung Cancer: A Real-World Study

Zhihua Liu, Q. Zhong, 2021, Cancer management and research.

Decreased lymphoma-related deaths and improved long-term relative survival with radiotherapy for early-stage diffuse large B-cell lymphoma in the rituximab era.

Shulian Wang, H. Fang, S. Qi, 2023, Radiotherapy and Oncology.

Prediction of 5‐year overall survival of diffuse large B‐cell lymphoma on the pola‐R‐CHP regimen based on 2‐year event‐free survival and progression‐free survival

Shulian Wang, Yueping Liu, H. Jing, 2024, Cancer medicine.

Multicenter phase II study of moderate low-dose radiotherapy in indolent non-Hodgkin lymphoma: CLCG-iNHL-01 protocol.

Yong-wen Song, Q. Zhong, S. Qi, 2024, Future oncology.